3/16/23 - Enzo Biochem (ENZ) stock is rising higher on an asset sale agreement. It’s selling its Clinical Laboratory division to Labcorp (LH). 3/20/23 - Monthly GD on MC. 8/23/23 - $3 per share.
Last week, ENZO BIOCHEM INC - NYSE:ENZ broke to higher ground and in the process, recaptured its 200 DMA out of a rounding bottom and now finds itself digesting/consolidating the move within a Flag pattern on lower volume as is evidenced in the Daily chart above. In addition, ENZ is now trading above all of its important moving averages 20/50/200 DMA's and...
ENZ is making a huge spike to the upside after the strong operating results. I'm expecting more upside for this one.